Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance
- medicalxpress.com language
- 2025-10-02 16:00 event
- 3 hours ago schedule

Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
It's not too late to turn it all around.View Entire Post ›
According to Instagram, Bieber counts the multitasking formula among her empties.View Entire Post ›
“I don’t know that I have ever heard a celebrity talk about a hot flash in the moment. Thank you for being so real.”View Entire Post ›
The Embryolisse Lait-Crème Concentré is a multi-tasking hidden gem of a facial cream.View Entire Post ›
After the model opened up about her experience being diagnosed with type 1 diabetes, we asked experts about the autoimmune condition, the differences between type 1 and type 2 diabetes, and how this diagnosis can change your life.View Entire Post ›
An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›
Past neuroscience studies have consistently showed the profound effects of early life experiences on the brain's wiring, particularly on the formation of the junctions that enable communication between neurons (i.e., synapses). The influence of early life experiences was found to be particularly pronounced during so-called sensitive periods (SPs), windows of time during which the brain's plasticity (i.e., its ability to form or reorganize neural connections) is heightened.
Obesity has long been acknowledged as a risk factor for a wide range of diseases, but a more precise link between obesity and Alzheimer's disease has remained a mystery—until now.
Researchers at Penn Medicine have identified specific brain circuits that are impacted by psilocybin—the active compound found in some psychedelic mushrooms—which could lead to new paths forward for pain and mental health management options.
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO) published in the journal Nature Medicine.
The makers of over a dozen sunscreens have halted sales in Australia after a consumer advocacy group analysis found many of them did not provide the sun protection factor their makers claimed.
There are not enough new tests and treatments in the pipeline to tackle the growing spread of drug-resistant bacteria, the World Health Organization warned Thursday.
The health care community has an important role in opposing the death penalty, argues an expert in The BMJ.
Commercial sunbeds should be banned in the UK, argue experts in The BMJ today.
The most comprehensive mapping to date of the global risk of chikungunya suggests India could experience the greatest long-term impact from the mosquito-borne virus.
A new developmental theory is reshaping how experts understand the reliability of children's and adolescents' memories of traumatic events and adverse experiences.
Forget the myth that exercise uses up your heartbeats. New Australian research shows fitter people use far fewer total heartbeats per day—potentially adding years to their lives.
Scientists from The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) report key findings about the underlying mechanisms of immune system stress response to protein misfolding, launching a new approach to cancer immunotherapy treatment targeting the protein production cycle.
It's time to get a flu vaccine, and pediatricians are urging people to get them after last winter, when the U.S. saw the most flu-related child deaths in 15 years.